Exposure to microgravity during spaceflight induces excessive osteoclast activation, resulting in bone loss and dysregulation of calcium metabolism. Accumulating evidence from spaceflight and ground-based studies suggests that endocrine factors involved in osteoclast inhibition may be altered under microgravity conditions; however, the underlying regulatory mechanisms remain incompletely understood.
Hirayama et al. (Thu,) studied this question.